Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose PK and Tolerability of Benapenem in Healthy Subjects
NCT03570970Phase 1Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Mar 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of benapenem in bacterial infection (3 arms), sponsored by Sihuan Pharmaceutical. Primary endpoints: Area Under the Curve from 0 to 24 hours, Maximum Observed Plasma Concentration at Day 7 and 2 more. Started Mar 2016; status: completed.
02
Drugs
benapenem
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03570970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03570970.